Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7934 results

Sort By:

Shared Decision-making and Colorectal Cancer Screening

Study ID: NCT04748380
Start Date: 2023-01-18
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

CRC decision aid pamphlet

Home Safety Pamphlet

Sponsor

Abramson Cancer Center at Penn Medicine

Source: clinicaltrials.gov

Share:
Add to list

Confirmatory Study of PRGN-2012 in Patients with RRP

Study ID: NCT06538480
Start Date: 2024-07-11
End Date: 2029-03-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

42

Intervention / Treatment

PRGN-2012

Sponsor

Precigen, Inc

Source: clinicaltrials.gov

Share:
Add to list

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

Study ID: NCT05546580
Start Date: 2022-11-14
End Date: 2025-11-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

50

Intervention / Treatment

Iadademstat

Gilteritinib Oral Tablet

Sponsor

Oryzon Genomics S.A.

Source: clinicaltrials.gov

Share:
Add to list

A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

Study ID: NCT06373380
Start Date: 2024-04-15
End Date: 2027-04
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

10

Intervention / Treatment

HB-200

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation

Study ID: NCT06840262
Start Date: 2020-08-10
End Date: 2027-02-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

45

Intervention / Treatment

Administration questionnaire

Regenerative Peripheral Nerve Interface Surgery

Targeted Muscle Reinnervation

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Study ID: NCT06928662
Start Date: 2025-09-01
End Date: 2028-03-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

Decitabine

Bone Marrow Aspiration

Bone Marrow Biopsy

Chest Radiography

Cytarabine

Echocardiography Test

Filgrastim

Fludarabine

Hematopoietic Cell Transplantation

Again

Multigated Acquisition Scan

Pheresis

Total-Body Irradiation

Biospecimen Collection

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Bladder and Bone Effects of Pelvic Radiation Therapy in Childhood Cancer Survivors

Study ID: NCT05818462
Start Date: 2023-07-11
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Uroflow testing

Bladder Scan

Dysfunctional Voiding Scoring System Survey

DEXA Scan of pelvis and sacral spine

Urine tests for specific biomarkers

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

Study ID: NCT04696029
Start Date: 2021-03-29
End Date: 2029-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

118

Intervention / Treatment

Difluoromethylornithine

Sponsor

Gielle Sholler

Source: clinicaltrials.gov

Share:
Add to list

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients with Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

Study ID: NCT04007029
Start Date: 2019-10-04
End Date: 2026-08-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

Chimeric Antigen Receptor T-Cell Therapy

Cyclophosphamide

Fludarabine Phosphate

Tocilizumab

Sponsor

Jonsson Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

Study ID: NCT04891289
Start Date: 2021-05-07
End Date: 2025-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

164

Intervention / Treatment

Gemcitabine

Oxaliplatin

Dexamethasone

Floxuridine (dirty)

Implanted Medical Device

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list